Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study - Concepedia

Concepedia

Publication | Open Access

Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study

DOI Full Paper Access

19

Citations

14

References

2022

Year

Jacob J. Henderson, Anirban Das, Daniel A. Morgenstern, Sumedha Sudhaman, Vanessa Bianchi, Jill Chung, Logine Negm, Melissa Edwards, David E. Kram, Michael Osborn,

JCO Precision Oncology

Cancer ImmunosurveillanceMedicineIrrdc StudyImmunologyImmune Checkpoint InhibitorSingle TherapyCancer TreatmentImmune Cell TherapyImmunotherapyOncologyCell BiologyCancer ResearchTumor MicroenvironmentTumor BiologyImmune Checkpoint Inhibition

References

	Year	Citations

Page 1

Page 1